Skip to main content
PMC home page
ACS Medicinal Chemistry Letters logoLink to ACS Medicinal Chemistry Letters
. 2019 Jul 9;10(8):1240. doi: 10.1021/acsmedchemlett.9b00278

Correction to “Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3”

Chuhui Huang, Si Si Liew, Grace R Lin, Anders Poulsen, Melgious J Y Ang, Brian C S Chia, Sin Yin Chew, Zekui P Kwek, John L K Wee, Esther H Ong, Priya Retna, Nithya Baburajendran, Rong Li, Weixuan Yu, Xiaoying Koh-Stenta, Anna Ngo, Sravanthy Manesh, Justina Fulwood, Zhiyuan Ke, Hwa Hwa Chung, Sugunavathi Sepramaniam, Xin Hui Chew, Nurul Dinie, May Ann Lee, Yun Shan Chew, Choon Bing Low, Vishal Pendharkar, Vithya Manoharan, Susmitha Vuddagiri, Kanda Sangthongpitag, Joma Joy, Alex Matter, Jeffrey Hill, Thomas H Keller, Klement Foo ✉
PMCID: PMC6691561  PMID: 31413812

The PDB ID given in the caption of Figure 3 is incorrect. The corrected caption can be seen below:

Figure 3. (A) Structure of compound 29 (orange) and SAM (pink) bound to SMYD3 (slate) (PDB ID: 6IJL). SMYD3 residues 3.5 Å away from 29 are shown in stick representation. (B) Overlay of structures of compounds 21 and 29 bound to SMYD3.

Articles from ACS Medicinal Chemistry Letters are provided here courtesy of American Chemical Society

RESOURCES